nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—POR—Doxorubicin—thyroid cancer	0.449	0.506	CbGbCtD
Nitrofurantoin—ABCG2—Vandetanib—thyroid cancer	0.223	0.251	CbGbCtD
Nitrofurantoin—ABCG2—Sorafenib—thyroid cancer	0.134	0.151	CbGbCtD
Nitrofurantoin—ABCG2—Doxorubicin—thyroid cancer	0.0815	0.0918	CbGbCtD
Nitrofurantoin—Haemoglobin decreased—Vandetanib—thyroid cancer	0.0039	0.0346	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Vandetanib—thyroid cancer	0.00379	0.0336	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Sorafenib—thyroid cancer	0.00374	0.0332	CcSEcCtD
Nitrofurantoin—Haemoglobin decreased—Sorafenib—thyroid cancer	0.00263	0.0233	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Sorafenib—thyroid cancer	0.00256	0.0227	CcSEcCtD
Nitrofurantoin—Pleural effusion—Sorafenib—thyroid cancer	0.00236	0.021	CcSEcCtD
Nitrofurantoin—Dyspnoea exertional—Epirubicin—thyroid cancer	0.00221	0.0196	CcSEcCtD
Nitrofurantoin—Polyneuropathy—Epirubicin—thyroid cancer	0.00205	0.0182	CcSEcCtD
Nitrofurantoin—Dyspnoea exertional—Doxorubicin—thyroid cancer	0.00205	0.0182	CcSEcCtD
Nitrofurantoin—Polyneuropathy—Doxorubicin—thyroid cancer	0.0019	0.0168	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00172	0.0152	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00149	0.0132	CcSEcCtD
Nitrofurantoin—Renal failure—Vandetanib—thyroid cancer	0.00148	0.0131	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Sorafenib—thyroid cancer	0.00139	0.0123	CcSEcCtD
Nitrofurantoin—Bundle branch block—Epirubicin—thyroid cancer	0.00133	0.0118	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Vandetanib—thyroid cancer	0.00127	0.0113	CcSEcCtD
Nitrofurantoin—Bundle branch block—Doxorubicin—thyroid cancer	0.00123	0.0109	CcSEcCtD
Nitrofurantoin—Alopecia—Vandetanib—thyroid cancer	0.00119	0.0106	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00118	0.0105	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00116	0.0103	CcSEcCtD
Nitrofurantoin—Eruption—Epirubicin—thyroid cancer	0.00109	0.00964	CcSEcCtD
Nitrofurantoin—Optic neuritis—Epirubicin—thyroid cancer	0.00109	0.00964	CcSEcCtD
Nitrofurantoin—Cough—Vandetanib—thyroid cancer	0.00102	0.00908	CcSEcCtD
Nitrofurantoin—Eruption—Doxorubicin—thyroid cancer	0.00101	0.00892	CcSEcCtD
Nitrofurantoin—Optic neuritis—Doxorubicin—thyroid cancer	0.00101	0.00892	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.001	0.0089	CcSEcCtD
Nitrofurantoin—Chest pain—Vandetanib—thyroid cancer	0.000999	0.00885	CcSEcCtD
Nitrofurantoin—Renal failure—Sorafenib—thyroid cancer	0.000995	0.00882	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000992	0.0088	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Vandetanib—thyroid cancer	0.000937	0.00831	CcSEcCtD
Nitrofurantoin—Nystagmus—Epirubicin—thyroid cancer	0.000936	0.0083	CcSEcCtD
Nitrofurantoin—Pleural effusion—Epirubicin—thyroid cancer	0.000873	0.00774	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000872	0.00773	CcSEcCtD
Nitrofurantoin—Nystagmus—Doxorubicin—thyroid cancer	0.000866	0.00768	CcSEcCtD
Nitrofurantoin—Amblyopia—Epirubicin—thyroid cancer	0.000866	0.00768	CcSEcCtD
Nitrofurantoin—Paraesthesia—Vandetanib—thyroid cancer	0.00086	0.00762	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Sorafenib—thyroid cancer	0.000859	0.00762	CcSEcCtD
Nitrofurantoin—Dyspnoea—Vandetanib—thyroid cancer	0.000853	0.00757	CcSEcCtD
Nitrofurantoin—Dyspepsia—Vandetanib—thyroid cancer	0.000843	0.00747	CcSEcCtD
Nitrofurantoin—Decreased appetite—Vandetanib—thyroid cancer	0.000832	0.00738	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000826	0.00733	CcSEcCtD
Nitrofurantoin—Constipation—Vandetanib—thyroid cancer	0.000819	0.00726	CcSEcCtD
Nitrofurantoin—Pleural effusion—Doxorubicin—thyroid cancer	0.000808	0.00717	CcSEcCtD
Nitrofurantoin—Alopecia—Sorafenib—thyroid cancer	0.000803	0.00712	CcSEcCtD
Nitrofurantoin—Amblyopia—Doxorubicin—thyroid cancer	0.000802	0.00711	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000783	0.00694	CcSEcCtD
Nitrofurantoin—Jaundice cholestatic—Epirubicin—thyroid cancer	0.000761	0.00675	CcSEcCtD
Nitrofurantoin—Abdominal pain—Vandetanib—thyroid cancer	0.000757	0.00671	CcSEcCtD
Nitrofurantoin—Body temperature increased—Vandetanib—thyroid cancer	0.000757	0.00671	CcSEcCtD
Nitrofurantoin—Anaemia—Sorafenib—thyroid cancer	0.000731	0.00648	CcSEcCtD
Nitrofurantoin—Leukopenia—Sorafenib—thyroid cancer	0.000708	0.00628	CcSEcCtD
Nitrofurantoin—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000704	0.00625	CcSEcCtD
Nitrofurantoin—Cough—Sorafenib—thyroid cancer	0.00069	0.00612	CcSEcCtD
Nitrofurantoin—Asthenia—Vandetanib—thyroid cancer	0.000687	0.00609	CcSEcCtD
Nitrofurantoin—Myalgia—Sorafenib—thyroid cancer	0.000674	0.00597	CcSEcCtD
Nitrofurantoin—Diarrhoea—Vandetanib—thyroid cancer	0.000655	0.00581	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000646	0.00573	CcSEcCtD
Nitrofurantoin—Dizziness—Vandetanib—thyroid cancer	0.000633	0.00561	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000632	0.00561	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Epirubicin—thyroid cancer	0.000628	0.00557	CcSEcCtD
Nitrofurantoin—Anorexia—Sorafenib—thyroid cancer	0.000616	0.00546	CcSEcCtD
Nitrofurantoin—Vomiting—Vandetanib—thyroid cancer	0.000609	0.0054	CcSEcCtD
Nitrofurantoin—Rash—Vandetanib—thyroid cancer	0.000604	0.00535	CcSEcCtD
Nitrofurantoin—Headache—Vandetanib—thyroid cancer	0.0006	0.00532	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000588	0.00522	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000581	0.00515	CcSEcCtD
Nitrofurantoin—Dyspnoea—Sorafenib—thyroid cancer	0.000576	0.0051	CcSEcCtD
Nitrofurantoin—Nausea—Vandetanib—thyroid cancer	0.000569	0.00504	CcSEcCtD
Nitrofurantoin—Dyspepsia—Sorafenib—thyroid cancer	0.000568	0.00504	CcSEcCtD
Nitrofurantoin—Decreased appetite—Sorafenib—thyroid cancer	0.000561	0.00498	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Epirubicin—thyroid cancer	0.000558	0.00495	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000557	0.00494	CcSEcCtD
Nitrofurantoin—Constipation—Sorafenib—thyroid cancer	0.000552	0.0049	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000528	0.00468	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000517	0.00458	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000515	0.00456	CcSEcCtD
Nitrofurantoin—Body temperature increased—Sorafenib—thyroid cancer	0.00051	0.00453	CcSEcCtD
Nitrofurantoin—Abdominal pain—Sorafenib—thyroid cancer	0.00051	0.00453	CcSEcCtD
Nitrofurantoin—Renal impairment—Epirubicin—thyroid cancer	0.00051	0.00452	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000476	0.00422	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Sorafenib—thyroid cancer	0.000476	0.00422	CcSEcCtD
Nitrofurantoin—Renal impairment—Doxorubicin—thyroid cancer	0.000472	0.00419	CcSEcCtD
Nitrofurantoin—Asthenia—Sorafenib—thyroid cancer	0.000463	0.00411	CcSEcCtD
Nitrofurantoin—Diarrhoea—Sorafenib—thyroid cancer	0.000442	0.00392	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000437	0.00388	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000428	0.0038	CcSEcCtD
Nitrofurantoin—Dizziness—Sorafenib—thyroid cancer	0.000427	0.00379	CcSEcCtD
Nitrofurantoin—Asthma—Epirubicin—thyroid cancer	0.00042	0.00372	CcSEcCtD
Nitrofurantoin—Eosinophilia—Epirubicin—thyroid cancer	0.000415	0.00368	CcSEcCtD
Nitrofurantoin—Vomiting—Sorafenib—thyroid cancer	0.000411	0.00364	CcSEcCtD
Nitrofurantoin—Rash—Sorafenib—thyroid cancer	0.000407	0.00361	CcSEcCtD
Nitrofurantoin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000405	0.00359	CcSEcCtD
Nitrofurantoin—Headache—Sorafenib—thyroid cancer	0.000405	0.00359	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000396	0.00351	CcSEcCtD
Nitrofurantoin—Asthma—Doxorubicin—thyroid cancer	0.000388	0.00344	CcSEcCtD
Nitrofurantoin—Eosinophilia—Doxorubicin—thyroid cancer	0.000384	0.00341	CcSEcCtD
Nitrofurantoin—Nausea—Sorafenib—thyroid cancer	0.000384	0.0034	CcSEcCtD
Nitrofurantoin—Drowsiness—Epirubicin—thyroid cancer	0.000374	0.00332	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000371	0.00329	CcSEcCtD
Nitrofurantoin—Renal failure—Epirubicin—thyroid cancer	0.000368	0.00326	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000367	0.00325	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Epirubicin—thyroid cancer	0.000349	0.0031	CcSEcCtD
Nitrofurantoin—Drowsiness—Doxorubicin—thyroid cancer	0.000346	0.00307	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000343	0.00304	CcSEcCtD
Nitrofurantoin—Renal failure—Doxorubicin—thyroid cancer	0.00034	0.00302	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000339	0.00301	CcSEcCtD
Nitrofurantoin—Hepatitis—Epirubicin—thyroid cancer	0.000336	0.00298	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000334	0.00296	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Doxorubicin—thyroid cancer	0.000323	0.00286	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Epirubicin—thyroid cancer	0.000318	0.00282	CcSEcCtD
Nitrofurantoin—Hepatitis—Doxorubicin—thyroid cancer	0.000311	0.00276	CcSEcCtD
Nitrofurantoin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000309	0.00274	CcSEcCtD
Nitrofurantoin—Chills—Epirubicin—thyroid cancer	0.000301	0.00267	CcSEcCtD
Nitrofurantoin—Alopecia—Epirubicin—thyroid cancer	0.000297	0.00263	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000294	0.00261	CcSEcCtD
Nitrofurantoin—Flatulence—Epirubicin—thyroid cancer	0.000288	0.00255	CcSEcCtD
Nitrofurantoin—Chills—Doxorubicin—thyroid cancer	0.000279	0.00247	CcSEcCtD
Nitrofurantoin—Alopecia—Doxorubicin—thyroid cancer	0.000275	0.00244	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000271	0.00241	CcSEcCtD
Nitrofurantoin—Anaemia—Epirubicin—thyroid cancer	0.00027	0.0024	CcSEcCtD
Nitrofurantoin—Flatulence—Doxorubicin—thyroid cancer	0.000267	0.00236	CcSEcCtD
Nitrofurantoin—Malaise—Epirubicin—thyroid cancer	0.000264	0.00234	CcSEcCtD
Nitrofurantoin—Vertigo—Epirubicin—thyroid cancer	0.000263	0.00233	CcSEcCtD
Nitrofurantoin—Leukopenia—Epirubicin—thyroid cancer	0.000262	0.00232	CcSEcCtD
Nitrofurantoin—Cough—Epirubicin—thyroid cancer	0.000255	0.00226	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000251	0.00223	CcSEcCtD
Nitrofurantoin—Anaemia—Doxorubicin—thyroid cancer	0.00025	0.00222	CcSEcCtD
Nitrofurantoin—Chest pain—Epirubicin—thyroid cancer	0.000249	0.00221	CcSEcCtD
Nitrofurantoin—Myalgia—Epirubicin—thyroid cancer	0.000249	0.00221	CcSEcCtD
Nitrofurantoin—Discomfort—Epirubicin—thyroid cancer	0.000246	0.00218	CcSEcCtD
Nitrofurantoin—Malaise—Doxorubicin—thyroid cancer	0.000244	0.00216	CcSEcCtD
Nitrofurantoin—Vertigo—Doxorubicin—thyroid cancer	0.000243	0.00216	CcSEcCtD
Nitrofurantoin—Leukopenia—Doxorubicin—thyroid cancer	0.000242	0.00215	CcSEcCtD
Nitrofurantoin—Confusional state—Epirubicin—thyroid cancer	0.000241	0.00213	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000239	0.00212	CcSEcCtD
Nitrofurantoin—Cough—Doxorubicin—thyroid cancer	0.000236	0.00209	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000234	0.00207	CcSEcCtD
Nitrofurantoin—Myalgia—Doxorubicin—thyroid cancer	0.00023	0.00204	CcSEcCtD
Nitrofurantoin—Chest pain—Doxorubicin—thyroid cancer	0.00023	0.00204	CcSEcCtD
Nitrofurantoin—Discomfort—Doxorubicin—thyroid cancer	0.000228	0.00202	CcSEcCtD
Nitrofurantoin—Anorexia—Epirubicin—thyroid cancer	0.000227	0.00202	CcSEcCtD
Nitrofurantoin—Confusional state—Doxorubicin—thyroid cancer	0.000223	0.00197	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000221	0.00196	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000217	0.00193	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000216	0.00192	CcSEcCtD
Nitrofurantoin—Paraesthesia—Epirubicin—thyroid cancer	0.000214	0.0019	CcSEcCtD
Nitrofurantoin—Dyspnoea—Epirubicin—thyroid cancer	0.000213	0.00189	CcSEcCtD
Nitrofurantoin—Somnolence—Epirubicin—thyroid cancer	0.000212	0.00188	CcSEcCtD
Nitrofurantoin—Anorexia—Doxorubicin—thyroid cancer	0.00021	0.00187	CcSEcCtD
Nitrofurantoin—Dyspepsia—Epirubicin—thyroid cancer	0.00021	0.00186	CcSEcCtD
Nitrofurantoin—Decreased appetite—Epirubicin—thyroid cancer	0.000207	0.00184	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000206	0.00183	CcSEcCtD
Nitrofurantoin—Constipation—Epirubicin—thyroid cancer	0.000204	0.00181	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000201	0.00178	CcSEcCtD
Nitrofurantoin—Paraesthesia—Doxorubicin—thyroid cancer	0.000198	0.00176	CcSEcCtD
Nitrofurantoin—Dyspnoea—Doxorubicin—thyroid cancer	0.000197	0.00175	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Epirubicin—thyroid cancer	0.000197	0.00174	CcSEcCtD
Nitrofurantoin—Somnolence—Doxorubicin—thyroid cancer	0.000196	0.00174	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000195	0.00173	CcSEcCtD
Nitrofurantoin—Dyspepsia—Doxorubicin—thyroid cancer	0.000194	0.00172	CcSEcCtD
Nitrofurantoin—Decreased appetite—Doxorubicin—thyroid cancer	0.000192	0.0017	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000191	0.00169	CcSEcCtD
Nitrofurantoin—Constipation—Doxorubicin—thyroid cancer	0.000189	0.00167	CcSEcCtD
Nitrofurantoin—Abdominal pain—Epirubicin—thyroid cancer	0.000189	0.00167	CcSEcCtD
Nitrofurantoin—Body temperature increased—Epirubicin—thyroid cancer	0.000189	0.00167	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000182	0.00161	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000181	0.0016	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Epirubicin—thyroid cancer	0.000176	0.00156	CcSEcCtD
Nitrofurantoin—Body temperature increased—Doxorubicin—thyroid cancer	0.000175	0.00155	CcSEcCtD
Nitrofurantoin—Abdominal pain—Doxorubicin—thyroid cancer	0.000175	0.00155	CcSEcCtD
Nitrofurantoin—Asthenia—Epirubicin—thyroid cancer	0.000171	0.00152	CcSEcCtD
Nitrofurantoin—Diarrhoea—Epirubicin—thyroid cancer	0.000163	0.00145	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000163	0.00144	CcSEcCtD
Nitrofurantoin—Asthenia—Doxorubicin—thyroid cancer	0.000158	0.0014	CcSEcCtD
Nitrofurantoin—Dizziness—Epirubicin—thyroid cancer	0.000158	0.0014	CcSEcCtD
Nitrofurantoin—Vomiting—Epirubicin—thyroid cancer	0.000152	0.00135	CcSEcCtD
Nitrofurantoin—Diarrhoea—Doxorubicin—thyroid cancer	0.000151	0.00134	CcSEcCtD
Nitrofurantoin—Rash—Epirubicin—thyroid cancer	0.00015	0.00133	CcSEcCtD
Nitrofurantoin—Headache—Epirubicin—thyroid cancer	0.000149	0.00133	CcSEcCtD
Nitrofurantoin—Dizziness—Doxorubicin—thyroid cancer	0.000146	0.00129	CcSEcCtD
Nitrofurantoin—Nausea—Epirubicin—thyroid cancer	0.000142	0.00126	CcSEcCtD
Nitrofurantoin—Vomiting—Doxorubicin—thyroid cancer	0.00014	0.00124	CcSEcCtD
Nitrofurantoin—Rash—Doxorubicin—thyroid cancer	0.000139	0.00123	CcSEcCtD
Nitrofurantoin—Headache—Doxorubicin—thyroid cancer	0.000138	0.00123	CcSEcCtD
Nitrofurantoin—Nausea—Doxorubicin—thyroid cancer	0.000131	0.00116	CcSEcCtD
